$VRSK

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

Original reporting
Published Sep 8, 2026, 3:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VRSK
Bearish
medium confidence
Mentioned
$VRSK
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$VRSKBearishMed
01

Why it matters

The downgrade may trigger short‑term selling pressure, but the underlying undervaluation metrics could attract value‑oriented investors.

02

Market read

Analyst target cut is a fresh catalyst that could influence VRSK's price action and sector peers.

03

What to watch

Strong profitability and growth scores could support a rebound if momentum improves.

Relevance 7/10Novelty 7/10Timing: September 8, 2026 (same‑day release)

Background

Barclays maintains Overweight on Verisk Analytics while adjusting its valuation lower, reflecting cautious sentiment amid recent insider sales.

Company-level read

Ticker impact

$VRSKBearishMedium confidence
Context

Barclays lowered Verisk Analytics' price target to $225 from $275 on Sep 8, 2026.

Expected impact

Potential short‑term price pressure as investors reassess valuation.

Evidence & confidence

Target reduction reflects cautious outlook despite maintaining Overweight; combined with insider selling, it may trigger sell‑offs.

Market effects

May prompt re‑valuation of other business‑services data providers.

Limited to U.S. insurers and related tech stocks.

Low global impact; primarily affects U.S. institutional investors.

Counterpoint

Despite the target cut, the stock remains 44% undervalued per GF metrics, offering a buying opportunity.

Key entities

  • Barclays

    Maintains Overweight rating, lowered price target.

  • Verisk Analytics

    Data and analytics provider for property‑casualty insurers.

Related articles

$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).

$VRSKMedAI 8/10

Verisk Analytics v. AccuLynx: Sorry, You Actually DO Have To Comply With That Second Request

The Delaware Court of Chancery ordered Verisk Analytics to continue pursuing FTC clearance for its $2.35 billion acquisition of AccuLynx, despite Verisk's attempt to terminate the deal. The court ruled that Verisk's termination was invalid due to its willful conduct in ending negotiations with a competitor, ServiceTitan. Verisk must now comply with a costly Second Request process, which typically takes many months to complete. The court's decision is notable as it is the first to compel a buyer